YZH-56087-15409 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-08
Registered in v-safe
2021-04-09
Dose 1 — Pfizer-BioNTech
2021-04-29
Dose 2 — Pfizer-BioNTech
2021-08-04
Health check-in — 3 months, dose 2
Feeling: Fair

Adult check-in
2022-05-01
Survey response — 12 months, dose 2
MedDRA: Migraine — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit

Free text: daily migraine

MedDRA releases: 2024-11 · check-in free text available
2022-05-01
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
2022-05-02
Call successful
Does not wish to fill out VAERS report

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-09	Pfizer-BioNTech	No
2	2021-04-29	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-05-01	Successful 2022-05-02	Does not wish to fill out VAERS report

Free text

Release 11 — 12 months, dose 2

2022-05-01

Symptoms: daily migraine

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Migraine	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release